AAP Letter: Payers Notified of Recommendations for Live, Attenuated Influenza Vaccine (LAIV) 2008
AAP Private Payer Advocacy Advisory Committee
| Official AAP letter to medical directors, dated December 20, 2007, notifying national carriers of the recent expansion of the recommendations by the Advisory Committee on Immunization Practices (ACIP) for the use of the live, attenuated influenza vaccine (LAIV) to include children 2 to 4 years of age. |
Sign In Now
To continue reading, you must be a member of the American Academy of Pediatrics (AAP).
Not a Member?
Join the AAP (application process involved)
Learn more about the AAP
|
